Evidence map›Paper›PMID 40357108›Full record

ReviewCureus2025

Interceptive Treatment of Class II Malocclusion in Pediatric Patients Using Clear Aligner Mandibular Advancement: A Systematic Review Following PRISMA Guidelines.

Ahmed S Khalil, Rawan S Alrehaili, Zainab Mahmoud, Rasha Alrashidi, Anwar Alkhalaf, Mohammed Abdelmaksoud, Loulwah Linjawi, Reem Alsahafi, Zainab Alghareeb, Fahad Bujbarah and 2 more

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. [Research advances in clear aligner].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2026
    Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ahmed S KhalilOrthodontics, Private Practice, Medina, SAU.
Rawan S AlrehailiDentistry, Private Practice, Medina, SAU.
Zainab MahmoudDentistry, Private Practice, Medina, SAU.
Rasha AlrashidiCollege of Dentistry, Vision College, Riyadh, SAU.
Anwar AlkhalafCollege of Dentistry, Vision College, Riyadh, SAU.
Mohammed AbdelmaksoudCollege of Dentistry, King Abdulaziz University, Jeddah, SAU.
Loulwah LinjawiCollege of Dentistry, King Abdulaziz University, Jeddah, SAU.
Reem AlsahafiCollege of Dentistry, King Abdulaziz University, Jeddah, SAU.
Zainab AlghareebCollege of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Fahad BujbarahCollege of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, SAU.
Nada ShahirCollege of Dentistry, King Khalid University, Abha, SAU.
Ali A AssiryPreventive Dental Science, Faculty of Dentistry, Najran University, Najran, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While conventional functional appliances have been widely used to manage Class II malocclusion in growing pediatric patients, advancements in interceptive treatments have introduced aligner mandibular advancement as a modern and aesthetic alternative. Despite its increasing popularity, the effectiveness of aligner mandibular advancement has not been systematically evaluated. This systematic review aimed to evaluate the effectiveness of interceptive aligner mandibular advancement in the treatment of Class II malocclusion in pediatric patients, focusing on skeletal, dental, and soft tissue outcomes. This review adhered to the Preferred Reporting Items for Systematic reviews and Meta-Analyses or PRISMA guidelines. Studies evaluating pediatric patients with Class II malocclusion treated with aligner mandibular advancement were included. The databases searched included PubMed, Cochrane Library, Web of Science, Embase, and Scopus, with searches conducted up to November 30, 2024, to identify relevant articles addressing the PICOS framework (Population, Intervention, Comparison, Outcome, and Study design). The focus questions were: How effective is clear aligner mandibular advancement in the treatment of pediatric patients with Class II malocclusion? What are its associated treatment outcomes? The ROBINS-I tool was used to assess the risk of bias. Data were synthesized narratively due to heterogeneity in study designs and outcomes. Nine studies with 426 participants were included, conducted between 2021 and 2024. Seven studies adopted retrospective designs, one study used a prospective design, and one relied on a survey-based design. Aligner mandibular advancement demonstrated effectiveness in reducing overjet and ANB while maintaining lower incisor inclination compared to conventional functional appliances. Soft tissue improvements were also reported. Patients favored aligner mandibular advancement over conventional functional appliances for its superior comfort, better aesthetics, and less breakage. However, most studies were retrospective, and the lack of randomized controlled trials limited the strength of the evidence. Clear aligner mandibular advancement appears to be an effective approach for managing Class II malocclusions in growing pediatric patients, offering the distinct advantage of maintaining lower incisor inclination compared to other conventional functional appliances. However, the evidence remains limited due to methodological constraints, including the lack of randomized controlled trials, small sample sizes, and inconsistencies in study designs.

Indexed as

aligner mandibular advancementclass ii malocclusionclear alignersfunctional applianceinterceptive treatmentinvisaligninvisalign mandibular advancementpediatric patients

Identifiers

PMID40357108
PMCPMC12066874

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.